Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Rigel Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
PDS Biotechnology Corporation August 10, 202673.3%
-
Rigel Pharmaceuticals Inc. May 22, 202597.9%
-
PDS Biotechnology Corporation July 14, 202367.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Rigel Pharmaceuticals Inc. | Open-market sale | −2,500 | $35.00 | $87,500 |
| May 26, 2026 | Rigel Pharmaceuticals Inc. | Open-market sale | −2,500 | $29.17 | $72,925 |
| May 15, 2026 | Rigel Pharmaceuticals Inc. | Grant or award | +5,750 | — | — |
| May 23, 2025 | Rigel Pharmaceuticals Inc. | Grant or award | +2,500 | — | — |
| May 25, 2024 | Rigel Pharmaceuticals Inc. | Grant or award | +25,000 | — | — |
| May 26, 2023 | Rigel Pharmaceuticals Inc. | Grant or award | +25,000 | — | — |
Questions about Kamil Ali-Jackson
What boards is Kamil Ali-Jackson on?
Kamil Ali-Jackson sits on the boards of PDS Biotechnology Corporation and Rigel Pharmaceuticals Inc.
How long has Kamil Ali-Jackson served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.